Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2620 studies found for:    "Fibrin Modulating Agents"
Show Display Options
Rank Status Study
1 Completed Tranexamic Acid in Reverse Total Shoulder Arthroplasty
Conditions: Shoulder Joint Disease;   Complications; Arthroplasty;   Intraoperative Complications;   Blood Loss, Surgical
Interventions: Drug: Tranexamic Acid;   Drug: Placebo
2 Completed Clinical Efficacy of Tranexamic Acid and ε-Aminocaproic Acid in Reducing Blood Loss Following Total Knee Replacement
Condition: Osteoarthritis
Interventions: Drug: Tranexamic Acid (TXA);   Drug: ε-Aminocaproic Acid (EACA)
3 Recruiting STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial
Conditions: Intracerebral Haemorrhage;   Stroke
Interventions: Drug: Tranexamic Acid;   Drug: Placebo
4 Terminated The Intravascular Cooling in the Treatment of Stroke 2/3 Trial
Condition: Stroke, Acute
Interventions: Device: hypothermia;   Other: Group1: IV t-PA and normothermia
5 Completed
Has Results
Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Intervention: Drug: Rivaroxaban (Xarelto, BAY59-7939)
6 Not yet recruiting IV Tranexamic Acid Prior to Hysterectomy
Conditions: Hysterectomy;   Blood Loss, Surgical
Interventions: Drug: Tranexamic Acid;   Drug: Sodium Chloride
7 Not yet recruiting A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes Mellitus
Condition: Type1 Diabetes Mellitus
Interventions: Drug: Insulin glulisine (U300);   Drug: Insulin glulisine;   Drug: Insulin aspart;   Drug: NPH insulin;   Drug: Glucagon;   Drug: Glucose;   Drug: Heparin
8 Not yet recruiting Safety and Efficacy of IV TXA in Reducing Blood Loss and Transfusion in Hip Fractures
Conditions: Hip Fractures;   Blood Loss
Interventions: Drug: Tranexamic Acid;   Drug: Placebo
9 Recruiting Impact of Neutrophil Extracellular Traps on Tissue Plasminogen Activator Induced Thrombolysis in Acute Ischemic Stroke Patients
Condition: Acute Stroke
Intervention:
10 Not yet recruiting Aspirin for Uncontrolled Asthma
Condition: Uncontrolled Asthma
Interventions: Drug: Aspirin;   Drug: Placebo
11 Not yet recruiting Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 75 Years and Over Suffering From Non Valvular Atrial Fibrillation (nv AF)
Condition: Non Valvular Atrial Fibrillation (nv AF)
Interventions: Drug: Non-exposed group;   Drug: Exposed group
12 Not yet recruiting n-Butylphthalide (NBP) Softgel Capsules in Stroke Patients
Condition: AIS
Interventions: Drug: NBP Softgel Capsules;   Drug: Placebo;   Drug: Aspirin
13 Recruiting Local Administration of Tranexamic Acid in Upper Gastrointestinal Hemorrhage
Conditions: Gastrointestinal Hemorrhage;   Tranexamic Acid;   Emergency Department;   Antifibrinolytic Agents
Interventions: Drug: Tranexamic acid 5%;   Drug: Placebo
14 Not yet recruiting Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI
Condition: Catheter-related Infections
Interventions: Drug: Standard of care with placebo lock (saline and heparin);   Drug: Standard of care with Mino-Lok Therapy (MLT);   Drug: Standard of Care with an antibiotic lock
15 Not yet recruiting STAT-STatin and Aspirin in Trauma
Conditions: Wounds and Injuries;   Venous Thromboembolism
Interventions: Drug: Aspirin and Rosuvastatin;   Drug: Placebo (for Aspirin and Rosuvastatin)
16 Active, not recruiting Anti Xa Activity in Cancer Patients Receiving Low-molecular-weight Heparin for Venous Thromboembolism
Conditions: Neoplasms;   Venous Thromboembolism
Intervention:
17 Not yet recruiting Bivalirudin in Acute Myocardial Infarction
Condition: Acute Myocardial Infarction
Interventions: Drug: Bivalirudin;   Drug: heparin
18 Not yet recruiting Aspirin and Renal Disease Progression in Patients With Type 2 Diabetes
Condition: Diabetes
Interventions: Drug: Aspirin;   Other: Placebo
19 Recruiting Optimal Coronary Flow After PCI for Myocardial Infarction - a Pilot Study
Condition: ST-segment Elevation Myocardial Infarction
Interventions: Drug: alteplase;   Drug: Placebo
20 Recruiting Assessment of Hemostasis Disorders in rtPA-treated Patients Requiring Endovascular Treatment for Ischemic Stroke
Condition: Stroke, Acute
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years